On October 26, 2017 Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology Company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, reported that it will host a teleconference and webcast with management to discuss the third quarter 2017 financial results, provide an update on the Company’s business, and discuss expectations for the future (Press release, Spectrum Pharmaceuticals, OCT 26, 2017, View Source [SID1234521203]).

Conference Call

Thursday, November 2, 2017 @ 4:30 p.m. Eastern/1:30 p.m. Pacific

Domestic: (877) 837-3910, Conference ID# 7488227
International: (973) 796-5077, Conference ID# 7488227

For interested individuals unable to join the call, a replay will be available from November 2, 2017 @ 7:30 p.m. ET/4:30 p.m. PT through November 12, 2017 until 11:59 p.m. ET/8:59 p.m. PT.

Domestic Replay Dial-In #: (855) 859-2056, Conference ID# 7488227
International Replay Dial-In #: (404) 537-3406, Conference ID# 7488227

This conference call will also be webcast. Listeners may access the webcast, which will be available on the investor relations page of Spectrum Pharmaceuticals’ website: www.sppirx.com on November 2, 2017 at 4:30 p.m. Eastern/1:30 p.m. Pacific.